Abstract:Background: Deep venous thrombosis (DVT) confers vein wall injury associated with fibrosis and extracellular matrix turnover. The activation of vascular smooth muscle cells (VSMCs) and phenotypic switching are postulated to be the significant contributing factors in the evolution of the pathogenic processes. This study investigated the effect of tissue plasminogen activator (tPA) on the phenotypic switching and collagen deposition of VSMCs, as well as related signaling pathway that leads to this activation.Materials and methods: The model of stasis-induced DVT was established by ligation of the femoral vein. VSMCs transfected with the plasmid vector carrying a rat recombinant tPA gene with an enhanced green fluorescent protein (EGFP) tag (AdtPA-EGFP). Fibrotic change, expression of collagen type I, the cell number of media, and intimal thickness score were evaluated; the comparisons were made among the AdtPA-EGFP-transfected group, an empty vector (AdNull-EGFP) transfected group, and a phosphate-buffered saline perfused group in vivo. tPA induced VSMCs phenotypic switching and collagen deposition in vitro. The related signaling pathway molecules and the cell cycle progression were also investigated by western blot and flow cytometry.Results: In the AdtPA-EGFP stasis DVT model, early vein wall collagenolysis and deposition occurred more remarkable. Histological studies showed that the expression of vein wall collagen type I protein, cell number of media, and intimal thickness score was significantly increased (P<0.05). In primary culture VSMCs, sustained stimulation with tPA induced collagen type I upregulation and triggered sequential signaling events involving Akt, extracellular signal-regulated kinases 1/2 (ERK1/2), glycogen synthase kinase-3 (GSK3)-beta phosphorylation, and cyclin D1 induction. Blockade of phosphatidylinositol 3-kinase-Akt and ERK1/2 activation suppressed tPA-induced GSK3 beta phosphorylation, cyclin D1 expression, and the deposition of collagen type I.Conclusions: tPA was a profibrotic factor that potentiated the phenotypic switching and the deposition of collagen in VSMC. The effect of tPA on VSMCs involved activation of Akt and ERK1/2 pathways and inhibition of GSK3 beta activity, which could promote a switch of the synthetic phenotype in VSMCs and lead to the remodeling of vascular injury. (C) 2013 Elsevier Inc. All rights reserved.

Effect of Tissue Plasminogen Activator on Vascular Smooth Muscle Cells.

Tissue plasminogen activator expression and barrier properties of human brain microvascular endothelial cells.

Gene transfer of tissue plasminogen activator mediated by pseudotyped retroviral vector and its effect on smooth muscle cell proliferation

[Effects of Co-Expression Plasmid of Human Tpa and VEGF165 on the Proliferation of Vascular Cells and Fibrinolysis Activity].

PDE4 regulates tissue plasminogen activator expression of human brain microvascular endothelial cells.

Role and Mechanism of Tissue Plasminogen Activator in Venous Wall Fibrosis Remodeling after Deep Venous Thrombosis Via the Glycogen Synthase Kinase-3 Beta Signaling Pathway.

Retroviral Vector-Mediated Transfer and Expression of Human Tissue Plasminogen Activator Cdna in Bovine Brain Endothelial Cells

Tissue plasminogen activator enhances mobilization of endothelial progenitor cells and angiogenesis in murine limb ischemia

Construction of Eukaryotic Expression Plasmid Containing Tpa Genes and Its Expression in Transfected VSMCs

Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation

Release of Matrix Metalloproteinases-2 and 9 by S-Nitrosylated Caveolin-1 Contributes to Degradation of Extracellular Matrix in Tpa-Treated Hypoxic Endothelial Cells

The expression of tPA gene transduced into endothelium of ECV304

Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression

Effects of Tissue Inhibitor of Matrix Metalloproteinase 2 Gene Transfer on Aortic Smooth Muscle Cells

[Effects of Platelet Derived Growth Factor Antisense Oligodeoxynucleotides and Tissue-Type Plasminogen Activator Gene Transfection on Inhibition of Intimal Proliferation].

Construction and Biological Activities of Human Tpa Eukaryotic Expression Plasmid.

Perturbation of Platelet Adhesion to Endothelial Cells by Plasminogen Activation in Vitro

Ultrasound-Targeting Transfection of Nano-Tissue-Type Plasminogen Activator Gene to Prevent In-Stent Thrombosis and Neointimal Hyperplasia after Stenting Intervention in Injured Rabbit Iliac Artery

Direct Transfer Of Transforming Growth-Factor-Beta-1 Gene Into Arteries Stimulates Fibrocellular Hyperplasia

In vivo expression of human tissue-plasminogen activator transfected AGZY83-a cells implanted in mice

Caveolin-1 mediates tissue plasminogen activator-induced MMP-9 up-regulation in cultured brain microvascular endothelial cells.